The recognition of miRNAs as significant modulators of numerous pathways, including adipogenesis, insulin sensitivity, and inflammatory response, suggests that understanding how zinc impacts miRNA function may bring a new perspective and lead to the development of novel therapeutic targets for obesity and its related diseases [3]. The gene discussed is INS; the disease is obesity disorder.